Professor Peter Friedland
Professor Peter Friedland is a surgeon scientist with a clinical, teaching, and collaborative research focus at Sir Charles Gairdner Hospital (SCGH) and Joondalup Health Campus, Perth, WA. As former Head of the ENT department of five consultants with an already established neurotology base, Peter has recruited and attracted an additional six fellowship trained consultants in the fields of anterior skull base rhinology, head and neck cancer and facial plastics, and encouraged two new fellowships in rhinology and head and neck cancer. He expanded the weekly head and neck cancer multidisciplinary team meeting at the hospital to commit to an evidence-based approach, including a confidential electronic database record – 30 specialist colleagues from 14 different disciplines now attend these meetings, including anatomic pathologists, head and neck and PET scan radiologists.
In his teaching capacity, Peter has participated in significant medical education curriculum changes. He is an Associate Professor in the Faculty of Health and Medical Sciences at The University of Western Australia (UWA) and Professor and former discipline leader for ENT training at the School of Medicine at The University of Notre Dame Australia in Fremantle. He teaches medical students and surgical trainees daily at both SCGH and the Joondalup Health Campus (JHC). His teaching and mentoring have been recognised with several awards. In addition, he has become the Western Australian (WA) chairperson of the regional surgical trainee committee of the Royal Australasian College of Surgeons (RACS).
Peter has contributed to clinical and innovative translational research, involving multidisciplinary teams, in otology, rhinology, laryngology and in head and neck cancer. As Head of Clinical Research at the Ear Science Institute of Australia, he partnered with UWA, Macquarie University and the Australian Alzheimer’s Research Foundation in a prospective trial to determine cognitive improvement after cochlear implantation and in a future trial on hearing aid usage in early dementia.
Currently, Peter has become a principal investigator for a multinational and West Australian trial investigating the virucidal efficacy of 0.5% povidone-iodine nasal spray in COVID-19 patients.